Skip to main content

Omnicell to Present at the 38th Annual J.P. Morgan Healthcare Conference

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps, founder, chairman, president and CEO, and Peter Kuipers, executive vice president and CFO, will be presenting at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA.

Date: Wednesday, January 15, 2020
Time: 04:30 p.m. PT
Location: Westin St. Francis Hotel, San Francisco, CA
Availability: The audio-webcast of the live presentation may be accessed by visiting:
http://ir.omnicell.com/communications/events-presentations

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and expert services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 6,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.

OMCL-E

Contacts:

Omnicell, Inc.
Peter Kuipers
Chief Financial Officer
800-850-6664, ext. 6180
peter.kuipers@omnicell.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.